Rabies virus uniquely reprograms the transcriptome of human monocyte-derived macrophages

Front Cell Infect Microbiol. 2023 Jan 31:13:1013842. doi: 10.3389/fcimb.2023.1013842. eCollection 2023.

Abstract

Macrophages are amongst the first immune cells that encounter rabies virus (RABV) at virus entry sites. Activation of macrophages is essential for the onset of a potent immune response, but insights into the effects of RABV on macrophage activation are scarce. In this study we performed high-throughput sequencing on RNA extracted from macrophages that were exposed to RABV for 48 hours, and compared their transcriptional profiles to that of non-polarized macrophages (M0), and macrophages polarized towards the canonical M1, M2a and M2c phenotypes. Our analysis revealed that RABV-stimulated macrophages show high expression of several M1, M2a and M2c signature genes. Apart from their partial resemblance to these phenotypes, unbiased clustering analysis revealed that RABV induces a unique and distinct polarization program. Closer examination revealed that RABV induced multiple pathways related to the interferon- and antiviral response, which were not induced under other classical polarization strategies. Surprisingly, our data show that RABV induces an activated rather than a fully suppressed macrophage phenotype, triggering virus-induced activation and polarization. This includes multiple genes with known antiviral (e.g. APOBEC3A, IFIT/OAS/TRIM genes), which may play a role in anti-RABV immunity.

Keywords: Lyssavirus; RNA sequencing; innate immunity; macrophage polarization; rabies virus (RABV); transcriptomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Humans
  • Macrophages / metabolism
  • Rabies virus* / genetics
  • Rabies*
  • Transcriptome

Substances

  • APOBEC3A protein, human
  • Antiviral Agents

Grants and funding

This work was funded through an Erasmus MC Fellowship 2019, project number 110581. CE is funded by a VENI Grant from the Netherlands Organization for Scientific Research (NWO-VENI 09150162010181).